Cargando…
Radioiodine Therapy of Graves' Disease and the Uptake Paradox
PURPOSE OF THE STUDY: Radioiodine ((131)I) therapy is approved and well-accepted modality for the treatment of hyperthyroidism. The dosage of (131)I for successful treatment is based on many factors; however, an objective tool to determine the dose was missing. In a retrospective study, we found tha...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6958960/ https://www.ncbi.nlm.nih.gov/pubmed/31949364 http://dx.doi.org/10.4103/ijnm.IJNM_158_19 |